Company: LIDRW
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001437749-25-015868
Chunk: 88

Company: AEye, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 88
---
IVE INCOME (LOSS) 

   The changes in accumulated other comprehensive income (loss) by component for the three months ended  March 31, 2025 and 2024 are as follows (in thousands):

       Unrealized gains on available-for-sale securities  
 Balance at December 31, 2024  $5 
 Other comprehensive gain, net of tax   1 
 Balance at March 31, 2025  $6 

       Unrealized gains (losses) on available-for-sale securities  
 Balance at December 31, 2023  $10 
 Other comprehensive loss, net of tax   (14)
 Balance at March 31, 2024  $(4)

    11.  NET LOSS PER SHARE 

   The following table sets forth the basic and diluted net loss per share attributable to common stockholders for the periods presented (in thousands, except share amounts and per share data):

       Three months ended March 31,  
   2025    2024  
 Numerator:         
 Net loss attributable to common stockholders  $(8,016) $(10,219)
 Denominator:         
 Weighted average common shares outstanding - Basic   17,448,617   6,352,835 
 Weighted average common shares outstanding - Diluted   17,448,617   6,352,835 
         
 Net loss per share attributable to common stockholders - Basic and Diluted  $(0.46) $(1.61)

   Due to net losses for the three months ended  March 31, 2025 and 2024, basic and diluted net loss per share were the same, as the effect of all potentially dilutive securities would have been anti-dilutive. The following table sets forth the anti-dilutive common share equivalents for the periods listed:

       Three months ended March 31,  
   2025    2024  
 Common stock options issued and outstanding   134,242   205,910 
 Unvested restricted stock units   401,857   494,216 
 Warrants   1,124,706   319,443 
 Common Stock Purchase Agreements   33,657,478   842,180 
 Conversion of convertible notes   2,975,504   — 
 ESPP   81,070   33,